Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK: How important is quality of life?

Nick Bansback; Sue Ward; Jonathan Karnon

doi:10.1007/s10198-004-0226-5

Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK: How important is quality of life?

Nick Bansback, Sue Ward, Jonathan Karnon

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	188-189
Number of pages	2
Journal	The European Journal of Health Economics
Volume	5
Issue number	2
DOIs	https://doi.org/10.1007/s10198-004-0226-5
Publication status	Published - May 2004
Externally published	Yes

Keywords

Gemcitabine
Economic evaluation
Expected value of information

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10198-004-0226-5Licence: In Copyright

Cite this

@article{f4beadff8ab84192a9524d75b89f3da7,

title = "Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK: How important is quality of life?",

keywords = "Gemcitabine, Economic evaluation, Expected value of information",

author = "Nick Bansback and Sue Ward and Jonathan Karnon",

year = "2004",

month = may,

doi = "10.1007/s10198-004-0226-5",

language = "English",

volume = "5",

pages = "188--189",

journal = "The European Journal of Health Economics",

issn = "1618-7598",

publisher = "Springer Verlag",

number = "2",

}

TY - JOUR

T1 - Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK

T2 - How important is quality of life?

AU - Bansback, Nick

AU - Ward, Sue

AU - Karnon, Jonathan

PY - 2004/5

Y1 - 2004/5

KW - Gemcitabine

KW - Economic evaluation

KW - Expected value of information

U2 - 10.1007/s10198-004-0226-5

DO - 10.1007/s10198-004-0226-5

M3 - Article

SN - 1618-7598

VL - 5

SP - 188

EP - 189

JO - The European Journal of Health Economics

JF - The European Journal of Health Economics

IS - 2

ER -